ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is -29.02.
| Share Price | ₹767.7 | Dec 12,2025 |
| Market Cap | ₹437.6 Cr | |
| Earnings-TTM | ₹-15.1 Cr | TTM-Standalone Results |
| Price/Earnings | -29.02x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹437.6 Cr] as on Dec 12,2025
(/) Earnings [ ₹-15.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -29.02x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay -29.02 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.29x.
- ALBERT DAVID 's operated at median p/e ratio of 8.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2025 at 26.92x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 8.08x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALBERT DAVID | -15.08 | -29.02 | 437.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.93 | 430,513.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.66 | 170,614.0 |
| CIPLA LTD | 5,453.86 | 22.47 | 122,555.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 59.93 | 128,245.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.67 | 106,803.0 |
| MANKIND PHARMA LTD | 1,767.06 | 50.92 | 89,972.9 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.80 | 93,484.2 |
| LUPIN LTD | 4,347.53 | 22.21 | 96,571.8 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.11 | 69,330.3 |
| ABBOTT INDIA LTD | 1,508.95 | 39.37 | 59,412.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -29.02x |
| Max industry PE | 68.66x |
| Median industry PE | 22.47x |
| Average industry PE | 30.28x |
You may also like the below Video Courses